Recursion Pharmaceuticals... (RXRX)
NASDAQ: RXRX
· Real-Time Price · USD
5.77
0.13 (2.30%)
At close: Aug 15, 2025, 3:59 PM
5.77
0.00%
After-hours: Aug 15, 2025, 06:13 PM EDT
Recursion Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 19.1M | 14.74M | 4.51M | 26.08M | 14.42M | 13.79M | 10.89M | 10.1M | 11.02M | 12.13M | 13.68M | 13.05M | 7.65M | 5.3M | 2.5M | 2.5M | 2.5M | 2.5M |
Cost of Revenue | 20.16M | 21.83M | 12.79M | 12.08M | 13.1M | 14.57M | 23.48M | 10.88M | 9.38M | 12.45M | 10.84M | 15.41M | 14.23M | 7.8M | 2.58M | 33.25M | 29.62M | 24.11M |
Gross Profit | -1.06M | -7.08M | -8.28M | 14M | 1.32M | -772K | -12.59M | -775K | 1.63M | -314K | 2.84M | -2.36M | -6.57M | -2.5M | -76K | -30.75M | -27.12M | -21.61M |
Operating Income | -176.23M | -191.37M | -183.77M | -98.35M | -100.54M | -96.34M | -109.13M | -99.55M | -81.72M | -69.86M | -60.98M | -62.57M | -66.19M | -55.98M | -64.96M | -46.4M | -40.93M | -30.48M |
Interest Income | 5.44M | n/a | 4.62M | 3.83M | 3.27M | 4.05M | 4.52M | 4.98M | 4.96M | 4.66M | 3.68M | 1.83M | 652K | 87K | n/a | 50K | 29K | 16K |
Pretax Income | -171.9M | -202.65M | -178.9M | -95.67M | -98.06M | -92.15M | -94.62M | -93.02M | -76.73M | -65.33M | -57.49M | -60.45M | -65.56M | -55.98M | -64.93M | -47.43M | -43.4M | -30.72M |
Net Income | -171.9M | -202.49M | -178.91M | -95.67M | -97.54M | -91.37M | -93M | -93.02M | -76.73M | -60.79M | -57.48M | -58.32M | -65.55M | -55.98M | -64.93M | -47.43M | -43.4M | -30.72M |
Selling & General & Admin | 46.65M | 54.65M | 77.19M | 37.76M | 31.83M | 31.41M | 30.46M | 29.2M | 28.29M | 22.87M | 19.84M | 19.49M | 21.2M | 21.07M | 19.2M | 15.69M | 13.85M | 8.94M |
Research & Development | 128.64M | 129.63M | 98.33M | 74.6M | 70.03M | 64.16M | 66.08M | 70.01M | 55.06M | 46.68M | 43.98M | 40.84M | 38.44M | 32.44M | 48.29M | 33.25M | 29.62M | 24.11M |
Other Expenses | -120K | n/a | n/a | n/a | -392K | 160K | n/a | n/a | n/a | -103K | n/a | -107K | -21K | -34K | 27K | -29K | n/a | n/a |
Operating Expenses | 175.17M | 184.28M | 175.49M | 112.36M | 101.86M | 95.57M | 96.54M | 98.78M | 83.35M | 69.55M | 63.82M | 60.22M | 59.62M | 53.48M | 67.46M | 48.9M | 43.43M | 32.98M |
Interest Expense | 480K | n/a | 605K | 553K | 394K | 20K | 26K | 25K | 26K | 19K | 13K | 13K | 14K | 14K | n/a | 220K | 2.5M | 249K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 195.33M | 206.11M | 188.31M | 124.44M | 114.96M | 110.13M | 120.02M | 109.65M | 92.73M | 82M | 74.66M | 75.63M | 73.84M | 61.28M | 67.46M | 48.9M | 43.43M | 32.98M |
Income Tax Expense | n/a | -158K | 7K | 167K | -523K | -779K | -1.63M | n/a | n/a | -4.54M | -13K | -2.13M | -14K | -2K | 19K | n/a | n/a | 233K |
Shares Outstanding (Basic) | 417.36M | 402.77M | 336.04M | 282.58M | 242.2M | 236.02M | 233.16M | 214.33M | 201.42M | 191.62M | 185.67M | 173.44M | 172.21M | 170.69M | 169.37M | 168.53M | 168.43M | 168.32M |
Shares Outstanding (Diluted) | 417.36M | 402.77M | 336.04M | 282.58M | 242.2M | 236.02M | 233.16M | 214.33M | 201.42M | 191.62M | 185.67M | 173.44M | 172.21M | 170.69M | 169.37M | 168.53M | 168.43M | 168.32M |
EPS (Basic) | -0.41 | -0.5 | -0.53 | -0.34 | -0.4 | -0.39 | -0.4 | -0.43 | -0.38 | -0.32 | -0.31 | -0.34 | -0.38 | -0.33 | -0.38 | -0.28 | -0.26 | -0.18 |
EPS (Diluted) | -0.41 | -0.5 | -0.53 | -0.34 | -0.4 | -0.39 | -0.4 | -0.43 | -0.38 | -0.32 | -0.31 | -0.34 | -0.38 | -0.33 | -0.38 | -0.28 | -0.26 | -0.18 |
EBITDA | -147.57M | -182.81M | -165.2M | -87.92M | -89.67M | -84.73M | -93.51M | -85.39M | -69.15M | -59.59M | -52.28M | -55.45M | -62.76M | -53.2M | -62.36M | -44.63M | -38.57M | -29.07M |
EBIT | -171.42M | -202.14M | -178.29M | -95.12M | -97.67M | -92.13M | -97.03M | -92.99M | -76.7M | -65.31M | -57.48M | -60.43M | -65.55M | -55.97M | -64.95M | -47.21M | -40.9M | -30.47M |
Depreciation & Amortization | 23.85M | 19.33M | 12.95M | 7.2M | 8M | 7.4M | 15.62M | 7.6M | 7.55M | 5.72M | 5.2M | 4.98M | 2.79M | 2.77M | 2.58M | 2.58M | 2.33M | 1.4M |